Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA warning letter
Pharma
Celltrion buy, Rexulti CRL, Glenmark-Hengrui—Fierce Pharma Asia
Celltrion bought a Lilly plant in the U.S. The FDA turned down Lundbeck and Otsuka's PTSD application. Hengrui and Glenmark signed an ADC deal.
Angus Liu
Sep 26, 2025 10:00am
J&J subsidiary slapped with FDA warning letter
Sep 23, 2025 2:22pm
Sun plant placed on FDA import alert over contamination issues
Sep 11, 2025 9:25am
Hikal slammed with warning letter after contamination reports
Sep 11, 2025 8:07am
Amneal gets warning letter related to its antibacterial recalls
Sep 4, 2025 9:05am
China biotech deals, Takeda, LaNova—Fierce Pharma Asia
Jul 18, 2025 9:04am
